Processa Pharmaceuticals (PCSA) EPS (2013 - 2026)
Processa Pharmaceuticals (PCSA) EPS from Jun 30, 2013 to Mar 31, 2026. The TTM Processa Pharmaceuticals (PCSA) EPS is -$6.63. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Processa Pharmaceuticals (PCSA) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +88.14% |
| 3 Years TTM | -45.94% |
| 5 Years TTM | -29.14% |
| 10 Years TTM | +0.30% |
| All Time TTM | +2.79% |
Annual EPS change of Processa Pharmaceuticals (PCSA)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$1.26 | -76.06% |
| 2025 | -$5.27 | +11.67% |
| 2024 | -$4.72 | -46.76% |
| 2023 | -$8.87 | -79.38% |
| 2022 | -$43.00 | +136.44% |
| 2021 | -$18.19 | -28.40% |
| 2020 | -$25.40 | +65.92% |
| 2019 | -$15.31 | +716.03% |
| 2017 | -$1.88 | -0.38% |
| 2016 | -$1.88 | -75.22% |
| 2015 | -$7.60 | -26.49% |
| 2014 | -$10.34 | +8.89% |
| 2013 | -$9.50 | N/A |
Comparison Processa Pharmaceuticals (PCSA) five years EPS CAGR with competitors
Processa Pharmaceuticals (PCSA) five years EPS CAGR is -22.78%.